Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Cash & Equivalents (2016 - 2026)

Scynexis filings provide 14 years of Cash & Equivalents readings, the most recent being $36.7 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 428.25% to $36.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $36.7 million, a 428.25% increase, with the full-year FY2025 number at $21.3 million, up 32.45% from a year prior.
  • Cash & Equivalents hit $36.7 million in Q1 2026 for Scynexis, up from $21.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $118.7 million in Q2 2022 to a low of $6.9 million in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $46.5 million (2025), compared with a mean of $58.3 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 92.63% in 2025 and later soared 428.25% in 2026.
  • Scynexis' Cash & Equivalents stood at $45.8 million in 2022, then dropped by 25.68% to $34.0 million in 2023, then crashed by 52.86% to $16.1 million in 2024, then surged by 32.45% to $21.3 million in 2025, then skyrocketed by 72.5% to $36.7 million in 2026.
  • The last three reported values for Cash & Equivalents were $36.7 million (Q1 2026), $21.3 million (Q4 2025), and $14.8 million (Q3 2025) per Business Quant data.